Tabotabo, Daisybel .

HRN: 29-50-27  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2026
CEFTRIAXONE 1G (VIAL)
08/19/2026
08/26/2026
IV
2G
OD
UTI, CHOLELITHIASIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary TractIntra-abdominal    Compliance to guidelines: